DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Zhang H, Xu X, Gajewiak J. et al.
Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo.
Cancer Res 2009;
69: 5441-5449
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.